viatris

Latest stories

  • in Health care

    US Supreme Court turns down Sanofi appeal to revive EpiPen suit against Viatris

    US Supreme Court turns down Sanofi appeal to revive EpiPen suit against Viatris

    by

    Washington: The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA to revive its antitrust lawsuit accusing rival pharmaceutical company Viatris Inc of illegally monopolizing the market with its EpiPen auto-injector, a device used to treat severe allergic reactions. The justices turned away Sanofi’s appeal of a lower court’s ruling rejecting the […] More

  • in Health care

    Teva, Viatris win US appeal in patent fight over Parkinson’s drug

    Teva, Viatris win US appeal in patent fight over Parkinson's drug

    by

    New Delhi: Belgian biopharmaceutical company UCB on Wednesday lost its U.S. court appeal seeking to revive a patent covering its Parkinson’s disease drug Neupro, clearing an obstacle for Teva’s Actavis Laboratories UT Inc and Viatris‘ Mylan Technologies Inc to sell generic versions of the drug. The U.S. Court of Appeals for the Federal Circuit agreed […] More